---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-26-001722"
form_type: "8-K"
ticker: "SLXN"
cik: "0002022416"
company_name: "Silexion Therapeutics Corp"
filed_at: "2026-03-25T23:59:59+00:00"
generated_at: "2026-05-15T09:06:29.422752+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Silexion Therapeutics removes director Ilan Levin effective March 25, 2026

## Summary
- Ilan Levin removed from Board on March 25, 2026 by unanimous vote of other directors.
- Removal effective immediately; no reason disclosed in filing.
- No replacement director named or resignation reported.

## SEC filing metadata
- accession: 0001178913-26-001722
- form_type: 8-K
- ticker: SLXN
- cik: 0002022416
- company_name: Silexion Therapeutics Corp
- filed_at: 2026-03-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2022416/000117891326001722/0001178913-26-001722-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2022416/000117891326001722/zk2634957.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-26-001722
- JSON: https://secwatch.observer/filing/0001178913-26-001722.json
- Plain text: https://secwatch.observer/filing/0001178913-26-001722.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.